Literature DB >> 21785934

Computer-assisted design for atenolol prodrugs for the use in aqueous formulations.

Rafik Karaman1, Khuloud Dajani, Hussein Hallak.   

Abstract

Based on stability studies on the drugs atenolol and propranolol and some of their derivatives it is believed that increasing the lipophilicity of the drug will lead to an increase in the stability of its aqueous solutions and will provide a prodrug system with the potential for releasing atenolol in a controlled manner. Using DFT theoretical calculations we have calculated an intramolecular acid catalyzed hydrolysis in nine maleamic (4-amino-4-oxo-2butenoic) acids (Kirby's N-alkylmaleamic acids), 1-9. The DFT calculations confirmed that the acid-catalyzed hydrolysis mechanism in these systems involves: (1) a proton transfer from the hydroxyl of the carboxyl group to the adjacent amide carbonyl carbon, (2) an approach of the carboxylate anion toward the protonated amide carbonyl carbon to form a tetrahedral intermediate; and (3) a collapse of the tetrahedral intermediate into products. Furthermore, DFT calculations in different media revealed that the reaction rate-limiting step depends on the reaction medium. In aqueous medium the rate-limiting step is the collapse of the tetrahedral intermediate whereas in the gas phase the formation of the tetrahedral intermediate is the rate-limiting step. Furthermore, the calculations establish that the acid-catalyzed hydrolysis efficiency is largely sensitive to the pattern of substitution on the carbon-carbon double bond. Based on the experimental t(1/2) (the time needed for the conversion of 50% of the reactants to products) and EM (effective molarity) values for processes 1-9 we have calculated the t(1/2) values for the conversion of the two prodrugs to the parental drug, atenolol. The calculated t(1/2) values for ProD 1-2 are predicted to be 65.3 hours and 11.8 minutes, respectively. Thus, the rate by which atenolol prodrug undergoes cleavage to release atenolol can be determined according to the nature of the linker of the prodrug (Kirby's N-alkylmaleamic acids 1-9).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785934     DOI: 10.1007/s00894-011-1180-7

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  18 in total

Review 1.  Prodrug approaches to the improved delivery of peptide drugs.

Authors:  W Wang; J Jiang; C E Ballard; B Wang
Journal:  Curr Pharm Des       Date:  1999-04       Impact factor: 3.116

2.  Relationship between rate and distance.

Authors:  Fredric M Menger; Ashley L Galloway; Djamaladdin G Musaev
Journal:  Chem Commun (Camb)       Date:  2003-09-21       Impact factor: 6.222

3.  Computer-assisted design of pro-drugs for antimalarial atovaquone.

Authors:  Rafik Karaman; Hussein Hallak
Journal:  Chem Biol Drug Des       Date:  2010-08-20       Impact factor: 2.817

4.  The effective molarity (EM)--a computational approach.

Authors:  Rafik Karaman
Journal:  Bioorg Chem       Date:  2010-04-10       Impact factor: 5.275

5.  The effective molarity (EM) puzzle in proton transfer reactions.

Authors:  Rafik Karaman
Journal:  Bioorg Chem       Date:  2009-05-05       Impact factor: 5.275

6.  Efficient intramolecular general acid catalysis of nucleophilic attack on a phosphodiester.

Authors:  Anthony J Kirby; Marcelo F Lima; Davi da Silva; Christo D Roussev; Faruk Nome
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

7.  Stereopopulation control. I. Rate enhancement in the lactonizations of 0-hydroxyhydrocinnamic acids.

Authors:  S Milstien; L A Cohen
Journal:  J Am Chem Soc       Date:  1972-12-27       Impact factor: 15.419

8.  Bioavailability of atenolol formulations.

Authors:  J Mcainsh; W T Simpson; B F Holmes; J Young; S H Ellis
Journal:  Biopharm Drug Dispos       Date:  1980 Oct-Dec       Impact factor: 1.627

9.  Development, validation and stability study of pediatric atenolol syrup.

Authors:  T Foppa; F S Murakami; M A S Silva
Journal:  Pharmazie       Date:  2007-07       Impact factor: 1.267

10.  Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits.

Authors:  Sang Chul Shin; Jun Shik Choi
Journal:  Eur J Pharm Biopharm       Date:  2003-11       Impact factor: 5.571

View more
  6 in total

1.  Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions.

Authors:  Rafik Karaman; Hiba Ghareeb; Khuloud Kamal Dajani; Laura Scrano; Hussein Hallak; Saleh Abu-Lafi; Gennaro Mecca; Sabino A Bufo
Journal:  J Comput Aided Mol Des       Date:  2013-07-24       Impact factor: 3.686

2.  Computationally designed prodrugs of statins based on Kirby's enzyme model.

Authors:  Rafik Karaman; Wajd Amly; Laura Scrano; Gennaro Mecca; Sabino A Bufo
Journal:  J Mol Model       Date:  2013-07-09       Impact factor: 1.810

3.  Prodrugs for masking bitter taste of antibacterial drugs--a computational approach.

Authors:  Rafik Karaman
Journal:  J Mol Model       Date:  2013-02-19       Impact factor: 1.810

4.  Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis--a computational approach.

Authors:  Rafik Karaman; Ghadeer Dokmak; Maryam Bader; Hussein Hallak; Mustafa Khamis; Laura Scrano; Sabino Aurelio Bufo
Journal:  J Mol Model       Date:  2012-09-02       Impact factor: 1.810

Review 5.  Enzyme Models-From Catalysis to Prodrugs.

Authors:  Zeinab Breijyeh; Rafik Karaman
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

6.  Design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations.

Authors:  Rafik Karaman; Alaa Qtait; Khulod Khayyat Dajani; Saleh Abu Lafi
Journal:  ScientificWorldJournal       Date:  2014-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.